"Alta Bates Summit Medical Center's Herrick Campus in Berkeley offers quality medical services and care to the San Francisco Bay Area."

During the past decade, Alta Bates Summit Medical Center-Herrick Campus conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 89 clinical trials were completed, i.e. on average, 104.7% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 48 clinical trials were completed. i.e. 208.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Alta Bates Summit Medical Center-Herrick Campus" #1 sponsor was "National Cancer Institute (NCI)" with 93 trials, followed by "SWOG Cancer Research Network" with 36 trials sponsored, "Alliance for Clinical Trials in Oncology" with 18 trials sponsored, "NRG Oncology" with 14 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 14 trials sponsored. Other sponsors include 49 different institutions and companies that sponsored additional 38 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Alta Bates Summit Medical Center-Herrick Campus" #1 collaborator was "National Cancer Institute (NCI)" with 96 trials as a collaborator, "NRG Oncology" with 31 trials as a collaborator, "Canadian Cancer Trials Group" with 11 trials as a collaborator, "SWOG Cancer Research Network" with 9 trials as a collaborator and "Cancer and Leukemia Group B" with 8 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 38 trials.

According to Clinical.Site data, the most researched conditions in "Alta Bates Summit Medical Center-Herrick Campus" are "Breast Cancer" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (10 trials), "Invasive Breast Carcinoma" (9 trials), "Recurrent Breast Carcinoma" (9 trials) and "Prostate Cancer" (8 trials). Many other conditions were trialed in "Alta Bates Summit Medical Center-Herrick Campus" in a lesser frequency.

Most popular intervention types in "Alta Bates Summit Medical Center-Herrick Campus" are "Drug" (189 trials), "Other" (122 trials), "Biological" (83 trials), "Procedure" (47 trials) and "Radiation" (47 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (68 trials), "Quality-of-Life Assessment" (48 trials), "Questionnaire Administration" (26 trials), "Bevacizumab" (25 trials) and "Paclitaxel" (25 trials). Other intervention names were less common.

The vast majority of trials in "Alta Bates Summit Medical Center-Herrick Campus" are 165 trials for "All" genders, 45 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "Alta Bates Summit Medical Center-Herrick Campus". undefined are not yet recruiting, 40 are recruiting, 84 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 77 completed trials in Alta Bates Summit Medical Center-Herrick Campus, 4 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Alta Bates Summit Medical Center-Herrick Campus, 5 "Phase 1" clinical trials were conducted, 105 "Phase 2" clinical trials and 132 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".